Disease Interception: Myths, Mountains, and Mole Hills

Area of Science:

• Oncology
• Cancer Research
• Preventive Medicine

Background:

• Malignant diseases progress over time, increasing genomic complexity and therapeutic resistance.
• Advanced cancers have low cure rates despite understanding disease progression.
• Focus remains on treating established disease rather than early interception.

Purpose of the Study:

• To define the challenges in developing early cancer interception strategies.
• To assess the inherent difficulties in overcoming these hurdles.
• To propose potential approaches for effective cancer interception.

Main Methods:

• Commentary and analysis of existing challenges in cancer interception research.
• Review of industry perspectives and motivations.
• Exploration of scientific and logistical barriers.

Main Results:

• Significant hurdles exist in developing and implementing early cancer interception.
• Pharmaceutical industry interest may be limited due to perceived challenges.
• A need exists to re-evaluate strategies for disease interception over treatment.

Conclusions:

• Early cancer interception is underdeveloped compared to treatment of advanced disease.
• Addressing the hurdles requires a concerted effort and innovative approaches.
• Shifting focus towards prevention and interception is critical for improving cancer outcomes.